Abbott Laboratories buy Benchmark Co.
Start price
10.10.25
/
50%
€115.06
Target price
10.10.26
€125.35
Performance (%)
-7.14%
Price
12.01.26
€106.84
Summary
This prediction is currently active. With a performance of -7.14%, the BUY prediction for Abbott Laboratories by Benchmark_Co_ is down slightly. This prediction currently runs until 10.10.26. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -0.946% | -0.946% |
| iShares Core DAX® | 2.331% | 5.140% |
| iShares Nasdaq 100 | 2.077% | 2.956% |
| iShares Nikkei 225® | 2.759% | 7.214% |
| iShares S&P 500 | 1.613% | 2.893% |
Comments by Benchmark_Co_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $145.00 price target on the stock.
Ratings data for ABT provided by MarketBeat